REVVITY, INC. (RVTY) Stock
4 members of Congress disclosed 15 trades in RVTY since 2025: 9 purchases and 6 sales, most recently Gilbert Cisneros (partial sale, Sep 9, 2026). 4 of the hedge funds AlphaScala tracks reported RVTY in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $162.14M. Company insiders reported 0 open-market buys and 3 sales on SEC Form 4 in the 90 days to Oct 21, 2026.
Which members of Congress traded REVVITY, INC. (RVTY)?
Most recent: Gilbert Cisneros (partial sale, Sep 9, 2026); records start Feb 25, 2025.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Gil Cisneros D-CA · House | 2026-09-09 | partial sale | $15k – $50k |
| Gil Cisneros D-CA · House | 2026-09-04 | partial sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-09-03 | partial sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-05-04 | purchase | $15k – $50k |
| Gil Cisneros D-CA · House | 2026-05-01 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2025-09-12 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2025-08-13 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2025-07-23 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 20, 2026.
See all RVTY political trades →Which hedge funds own RVTY?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 1.46M | $162.14M | +2226% |
| Marshall Wace | 114K | $12.63M | +787% |
| Millennium Management Israel Englander | 75K | $8.37M | NEW |
| Bridgewater Associates Ray Dalio | 24K | $2.69M | -35% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are REVVITY, INC. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Gonzales Anita | VP and CAO | SELL | 84 | $13K |
| Sep 21, 26 | Krakowiak Maxwell | Please See Remarks | SELL | 1.6K | $236K |
| Sep 16, 26 | Vohra Tajinder S | Please See Remarks | SELL | 7.3K | $1.0M |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →RVTY price chart
Powered by TradingViewWhat does REVVITY, INC. do?
Revvity Inc. is a global life sciences and diagnostics company that provides health science solutions, technologies, expertise, and services delivering complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The company operates through two primary segments: life sciences, which supplies reagents, instruments, and software for biopharma and academic research; and diagnostics, offering tools in immunodiagnostics, newborn screening, and reproductive health. Revvity Inc. serves major markets including the US, Europe, and China, supporting sectors such as healthcare, research, and biopharmaceutical development. Its products and services enable advancements in health sciences by providing end-to-end solutions for scientific discovery and clinical applications. Founded in 1937 and headquartered in Waltham, Massachusetts, Revvity Inc. plays a significant role in the diagnostics and research industry.